Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors.
about
Metformin and body weightEfficacy of alogliptin in type 2 diabetes treatment: a meta-analysis of randomized double-blind controlled studiesInnovative Thoughts on Treating Diabetes from the Perspective of Traditional Chinese MedicineGlobal Changes in Food Supply and the Obesity Epidemic.Bias in recording of body mass index data in the electronic health record.LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial.Screening for diabetes among Roma people living in SerbiaObesity among Sudanese adults with diabetes: a population-based survey.Effects of aquajogging in obese adults: a pilot study.Cardiovascular impact of drugs used in the treatment of diabetesBariatric surgery for people with diabetes and morbid obesity: an evidence-based analysisComparison of efficacy between incretin-based therapies for type 2 diabetes mellitusThe effects of high-intensity interval training on glucose regulation and insulin resistance: a meta-analysis.The importance of weight management in type 2 diabetes mellitus.Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review.Prevalence of diabetes mellitus in a Saudi communityEffects of exercise on cardiovascular risk factors in type 2 diabetes: a meta-analysis.Sodium glucose co-transport 2 inhibitors in the treatment of type 2 diabetes mellitus: a meta-analysis of randomized double-blind controlled trialsDistorted self-perceived weight status and underestimation of weight status in diabetes mellitus type 2 patients.Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin.Dosing of U-100 insulin and associated outcomes among Medicare enrollees with type 1 or type 2 diabetesThe effect of vitamin D supplementation on insulin and glucose metabolism in overweight and obese individuals: systematic review with meta-analysis.Incidence of diabetes mellitus type 2 complications among Saudi adult patients at primary health care center.Prevalence of Obesity and Its Influence on Achievement of Cardiometabolic Therapeutic Goals in Chinese Type 2 Diabetes Patients: An Analysis of the Nationwide, Cross-Sectional 3B Study.Application of the Ontario Diabetes Economic Model (ODEM) to Determine the Cost-effectiveness and Budget Impact of Selected Type 2 Diabetes Interventions in Ontario.Higher body mass index and lower intake of dairy products predict poor glycaemic control among Type 2 Diabetes patients in Malaysia.Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitor: Comparing Trial Data and Real-World Use.Obesity, diabetes and atrial fibrillation; epidemiology, mechanisms and interventions.Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study.Characterization of Patients with Type 2 Diabetes according to Body Mass Index: Korea National Health and Nutrition Examination Survey from 2007 to 2011.Dietary supplementation with long-chain monounsaturated fatty acids attenuates obesity-related metabolic dysfunction and increases expression of PPAR gamma in adipose tissue in type 2 diabetic KK-Ay miceNew players for advanced prostate cancer and the rationalisation of insulin-sensitising medicationSelf-reported receipt of healthcare professional's weight management counselling is associated with self-reported weight management behaviours of type 2 diabetes mellitus patients.Obesity in hospitalized type 2 diabetes patients: a descriptive study.Can Time Efficient Exercise Improve Cardiometabolic Risk Factors in Type 2 Diabetes? A Pilot StudyCardiovascular disease, hypertension, dyslipidaemia and obesity in patients with hypothalamic-pituitary disease.Clinical profile of long-term survivors and nonsurvivors with type 2 diabetes.Influences of weight loss on long-term diabetes outcomes.Obesity and cognitive dysfunction in heart failure: the role of hypertension, type 2 diabetes, and physical fitness.Management of the metabolic syndrome and type 2 diabetes through lifestyle modification.
P2860
Q22250988-6739C71B-5157-4627-ABB4-BD3D00FBB94CQ24288949-A201016F-5977-4158-9D53-D54FD844A05FQ26778650-9218FD7C-6F6B-4E57-A9D7-54E880AC8511Q30244927-4CF467C1-B273-4EF9-A1E9-E32BCB1AF779Q30707403-B77F7F57-3C09-4A7E-8299-958AF848C42DQ31044140-BE4AEC1C-833C-4408-A775-0ED053CEE0E8Q33809557-B59C817A-10E4-46A9-9F10-AFCBC9680D3AQ33871533-4712480E-28B4-4037-9597-6712E8EDC32EQ34042460-E956D34E-1B96-4500-AA55-6E73630BA3DFQ34383575-C6687AAC-0A4D-4316-ABB5-CF36083C3CA0Q34449280-C1F3C2A9-DAD8-4603-AFFB-19C23314EBB1Q34496741-AA5EB35B-CE75-4619-93E5-73B24CFCA320Q34498555-D9111492-0A09-4005-BCC0-E26832B465BDQ34547464-5FD99E22-6C4C-4036-9D5A-B8FA83163940Q35003229-D694EFAE-96D4-45B9-8529-27ED13946F51Q35006084-BAC90932-3FD1-4F08-8658-D2D51044C475Q35043813-B978C7D3-AAF0-4365-BC6D-75EE2BAD379DQ35068181-AD13AD9D-F0D9-4735-8A7B-AA89A468F9F7Q35149228-90486609-588B-4E58-8648-5CF1DC311F89Q35322859-C5587A62-3AEE-4CC8-BD03-4AEEDB553233Q35766301-86CEA183-235D-48A7-9120-6FC7AD241428Q35834308-B43B1BE5-4FB4-4C28-AE79-6C489CD046E6Q35844941-05FD78A4-7A47-4184-960A-FAC0F854D389Q35883847-74BE6A4E-17DD-46B2-920A-CA71AB97FF3DQ36040075-24C61BBA-D6BD-4EAF-A55D-89DDBF22D1B4Q36289603-B373BA6C-53DA-4895-BFB6-F8FBF44293FCQ36316732-5F9AD76D-B0EA-45C0-A667-0E992C0B110AQ36382360-D8124D0D-D34F-4DF0-A410-F3E5DEAF2456Q36429733-9ECEE84C-946A-434E-B2B8-E208D0A32916Q36489155-09FE1B62-98F7-4775-B1FF-355085E343CFQ36604200-51E592C6-7B98-463A-B073-2E1731C96C34Q36734036-A119319E-6EB5-444D-89F8-FD86CE8EFDE8Q36740027-CA797373-4063-4A01-A43E-EDEEBD8BAD0AQ36858616-A8A62179-0949-448D-AAC5-FA87507040AAQ36933579-4BD95599-BDAE-4FFE-A608-391C559C9476Q37008652-2A76F822-7E33-478B-88D8-2FBF7A7592E7Q37022541-27A9BB9C-F46A-47A8-8D35-3589060C1B34Q37072014-54096BAD-868C-48E3-817D-6EA03BCFF863Q37204307-5949BE92-A7D3-4337-BE65-B13C9AD76F00Q37463193-1048794A-6B2D-40AF-8987-49227B272722
P2860
Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Prevalence of obesity in type ...... h cardiovascular risk factors.
@en
type
label
Prevalence of obesity in type ...... h cardiovascular risk factors.
@en
prefLabel
Prevalence of obesity in type ...... h cardiovascular risk factors.
@en
P2093
P2860
P921
P356
P1476
Prevalence of obesity in type ...... th cardiovascular risk factors
@en
P2093
P2860
P304
P356
10.1136/PMJ.2005.039032
P407
P50
P577
2006-04-01T00:00:00Z